{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1239","upperLimit":"1995","value":"1572"},{"groupId":"OG001","lowerLimit":"185","upperLimit":"388","value":"268"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"49"},{"groupId":"OG001","value":"44"}],"units":"Participants"}],"title":"Age<24 years"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1013","upperLimit":"2126","value":"1467"},{"groupId":"OG001","lowerLimit":"131","upperLimit":"566","value":"272"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"22"}],"units":"Participants"}],"title":"Age>=24 years"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1328","upperLimit":"2002","value":"1630"},{"groupId":"OG001","lowerLimit":"200","upperLimit":"398","value":"282"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"57"}],"units":"Participants"}],"title":"Baseline HIV viral load <=75"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"441","upperLimit":"1894","value":"914"},{"groupId":"OG001","lowerLimit":"51","upperLimit":"795","value":"201"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"9"}],"units":"Participants"}],"title":"Baseline HIV viral load >75"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1123","upperLimit":"2156","value":"1556"},{"groupId":"OG001","lowerLimit":"218","upperLimit":"590","value":"359"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"24"}],"units":"Participants"}],"title":"Baseline CD4 <=500"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1178","upperLimit":"1967","value":"1522"},{"groupId":"OG001","lowerLimit":"145","upperLimit":"359","value":"229"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"49"},{"groupId":"OG001","value":"42"}],"units":"Participants"}],"title":"Baseline CD4 >500"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1040","upperLimit":"1857","value":"1390"},{"groupId":"OG001","lowerLimit":"151","upperLimit":"395","value":"245"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"40"},{"groupId":"OG001","value":"37"}],"units":"Participants"}],"title":"Nadir CD4 <=350"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1303","upperLimit":"2354","value":"1752"},{"groupId":"OG001","lowerLimit":"186","upperLimit":"528","value":"313"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"27"}],"units":"Participants"}],"title":"Nadir CD4>350"}],"denoms":[{"counts":[{"groupId":"OG000","value":"76"},{"groupId":"OG001","value":"66"}],"units":"Participants"}],"description":"Geometric mean concentration of antibodies for HPV 16 at 7 and 24 months","dispersionType":"95% Confidence Interval","groups":[{"description":"Month 7 visit after enrollment","id":"OG000","title":"Month 7 Visit"},{"description":"Month 24 visit after enrollment","id":"OG001","title":"Month 24 Visit"}],"paramType":"GEOMETRIC_MEAN","populationDescription":"Eligible participants who received at least one vaccination and who were sero-negative for HPV 16 at baseline with evaluable serum assessments.","reportingStatus":"POSTED","timeFrame":"at 7 and 24 Months","title":"Geometric Mean Titers for HPV 16 According to Participant Age, HIV Viral Load, CD4+ T Cell Count, and Nadir CD4 Level","type":"SECONDARY","unitOfMeasure":"mMU/mL"}